Home › Funds › D. E. Shaw & Co › FDMT
D. E. Shaw & Co position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)44.35K sh
Reported value held$589.91K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 25.67K | $179.00K | New |
| Q3 2022 | 10.04K | $81.00K | Reduce |
| Q4 2022 | 189.39K | $4.21M | Add |
| Q1 2023 | 81.46K | $1.40M | Reduce |
| Q1 2024 | 43.75K | $1.39M | New |
| Q2 2024 | 43.43K | $911.51K | Reduce |
| Q3 2024 | 39.15K | $423.21K | Reduce |
| Q4 2024 | 36.03K | $200.70K | Reduce |
| Q1 2025 | 25.34K | $81.85K | Reduce |
| Q2 2025 | 21.14K | $78.41K | Reduce |
| Q3 2025 | 10.10K | $87.77K | Reduce |
| Q4 2025 | 111.82K | $838.66K | Add |
| Q1 2026 | 24.03K | $223.72K | Reduce |
| Q2 2026 | 44.35K | $589.91K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026